About
Guillermo Herrera is a Research Analyst at Cramer Rosenthal McGlynn, LLC, based in New York, NY. Joining the firm in 2024, he serves as a generalist analyst within the investment group, delivering research across various sectors with a prior focus on industrials, including commercial vehicle OEMs, suppliers, and related industrial companies. His analytical coverage spans both U.S. and international equities, leveraging sector rotation and fundamental valuation approaches.
Before joining CRM, Herrera was an Equity Research Analyst at Gabelli Funds, where he specialized in the industrials sector, particularly commercial vehicles and their supply chains. Earlier, he gained experience with sustainable investing and ESG-centric emerging markets during his time at Artisan Partners. He also worked in strategic finance roles within pharmaceutical and healthcare technology companies, further broadening his asset class expertise.
Herrera holds a Master of Business Administration from Columbia Business School—where he was awarded the Robert H. Montgomery Prize in Accounting—and a Bachelor of Arts in Economics and Mathematics from Boston College. He also holds a degree from Universidad Carlos III de Madrid and is a CFA charterholder, reflecting his deep quantitative and analytical skills in equity research and investment analysis.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Cramer Rosenthal McGlynn, LLC | Research Analyst | Apr 2024 to Present | — |
| Gabelli Funds | Equity Research Analyst | Jul 2023 to Apr 2024 | — |
| Artisan Partners | Summer Equity Analyst - Sustainable (ESG) Emerging Markets | May 2022 to Aug 2022 | — |
| Amwell | Lead Financial Analyst | Sep 2019 to Apr 2021 | — |
| Alexion Pharmaceuticals, Inc. | Manager - Corporate and Business Development Finance | Jul 2019 to Sep 2019 | — |
| Alexion Pharmaceuticals, Inc. | Senior Analyst - Corporate and Business Development Finance | May 2018 to Jul 2019 | — |
| Alexion Pharmaceuticals, Inc. | Senior Analyst - Corporate and Business Development Finance | May 2018 to Jul 2019 | — |
| Alexion Pharmaceuticals, Inc. | Senior Analyst - Corporate and Business Development Finance | May 2018 to Jul 2019 | • Constructed NPV analyses for clinical stage assets, providing R&D organization a basis for annual portfolio prioritization • Managed annual operating plan & budget for the Global Commercial business... |
| Andersen Tax | Senior Associate - Business Valuations | Jan 2017 to May 2018 | • Valued companies utilizing discounted cash flow, market multiple and precedent transaction methods • Modeled purchase price allocations for acquisitions within spaces including Software, Biotechnolo... |
| Oracle | Business Development Intern | Jun 2013 to Aug 2013 | — |
| Andersen Tax | Associate - Business Valuations | Sep 2014 to Dec 2016 | • Valued companies utilizing discounted cash flow, market multiple and precedent transaction methods • Modeled purchase price allocations for acquisitions within spaces including Software, Biotechnolo... |
| Serfindata | Alternative Investment Research Intern | May 2012 to Aug 2012 | — |
Education
Columbia Business School
Master of Business Administration - MBA
2021 — 2023
Boston College
Bachelor of Arts (B.A.), Economics, Mathematics
2010 — 2014
Universidad Carlos III de Madrid
Economics, Mathematics
2012 — 2012
Skills & Expertise
Others at Cramer Rosenthal Mcglynn LLC (8)
| Name | Role | Location |
|---|---|---|
A Andrey Belov | Research Analyst | Stamford, CT , United States |
B Brian Harvey | Equity Portfolio Manager | United States |
K Kevin Chin | Portfolio Manager | Darien, CT , United States |
| Portfolio Manager | Rockville Centre, NY , United States | |
| AVP and Head of Trading | New York, NY , United States | |
T Tristan Newkirk | Research Analyst | New York, NY , United States |
J Jack Haverty | Research Analyst | New York, NY , United States |
J Jeffrey Yanover | Portfolio Manager | New York, NY , United States |
Similar Fund Managers
| Name | Role | Fund | Location |
|---|---|---|---|
A Alex D | Partner | Permian Investment Partners, LP | New York, NY , United States |
| Analyst | Permian Investment Partners, LP | Dallas, TX , United States |